Visceral obesity and the risk of ischaemic heart disease: Insights from the Québec Cardiovascular Study

Growth Hormone and IGF Research

Volumn 8, Issue SUPPL. 2, 1998, Pages 1-8

  Lamarche, B ^a   Lemieux, S ^a   Dagenais, G R ^b   Despres J P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN;

ADULT; ATHEROGENESIS; BODY FAT; CANADA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; HYPERLIPOPROTEINEMIA TYPE 2; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; OBESITY; PARTICLE SIZE; POPULATION RISK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK MANAGEMENT; SYNDROME X;

EID: 0032468846     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1096-6374(98)80018-x     Document Type: Article

References (3)

1. Larsson B, Björntorp P, Tibblin G. The health consequences of moderate obesity. Int J Obes 1981; 5: 97-116.
2. Vague J. [Sexual differentiation, a factor affecting the forms of obesity]. Presses Médicales 1947; 30: 339-340.
3. Kissebah AH, Vydelingum N, Murray R et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-260.